author-photo

Laura Guerrero

Hackensack University Medical Center

2

Papers

29

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Phase I study of carfilzomib, lenalidomide, vorinostat, and dexamethasone in patients with relapsed and/or refractory multiple myeloma.

2015 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (24)
A phase I study of carfilzomib, lenalidomide, vorinostat, and dexamethasone (QUAD) in relapsed and/or refractory multiple myeloma (MM).

2014 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (5)